In bladder carcinogenesis, ZNF224, interacting with the transcriptional co-repressor DEPDC1, downregulates the expression of A20, a negative regulator of the NF-kB pathway [29], whereas, in breast cancer, ZNF224 acts as an oncogenic transcriptional activator. This evidence concerns the gene ZNF224 and breast cancer.